4 ms·
The regulation and risk-aversion is far more impactful than the funding. It's not entirely unwarranted regulation, but fundamentally Intel can mess up 20 batch
by bpodgursky 4y ago
The regulation and risk-aversion is far more impactful than the funding.
It's not entirely unwarranted regulation, but fundamentally Intel can mess up 20 batches of 5nm chips before getting it right, and nobody cares. If a CRISPR trial kills someone, it's a BIG DEAL, and could potentially set the field back by years.